

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.78766529 |
| 2 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.09593636 |
| 3 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.98095929 |
| 4 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.87973266 |
| 5 | sodium ion export (GO:0071436) | 3.56669577 |
| 6 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.52918321 |
| 7 | alanine transport (GO:0032328) | 3.47359395 |
| 8 | synaptic vesicle maturation (GO:0016188) | 3.35336762 |
| 9 | glutamate secretion (GO:0014047) | 3.26535295 |
| 10 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.26309175 |
| 11 | low-density lipoprotein particle remodeling (GO:0034374) | 3.24636387 |
| 12 | presynaptic membrane assembly (GO:0097105) | 3.23139488 |
| 13 | daunorubicin metabolic process (GO:0044597) | 3.22060853 |
| 14 | polyketide metabolic process (GO:0030638) | 3.22060853 |
| 15 | doxorubicin metabolic process (GO:0044598) | 3.22060853 |
| 16 | cerebellar granule cell differentiation (GO:0021707) | 3.22006966 |
| 17 | cell communication by electrical coupling (GO:0010644) | 3.14653019 |
| 18 | retinal rod cell development (GO:0046548) | 3.06199357 |
| 19 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.05452171 |
| 20 | positive regulation of glycolytic process (GO:0045821) | 3.04957060 |
| 21 | L-amino acid import (GO:0043092) | 3.01109667 |
| 22 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.00169123 |
| 23 | xenobiotic catabolic process (GO:0042178) | 2.99863305 |
| 24 | cellular potassium ion homeostasis (GO:0030007) | 2.98100083 |
| 25 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.96650541 |
| 26 | regulation of skeletal muscle contraction (GO:0014819) | 2.96167966 |
| 27 | energy homeostasis (GO:0097009) | 2.94717230 |
| 28 | muscle filament sliding (GO:0030049) | 2.92973855 |
| 29 | actin-myosin filament sliding (GO:0033275) | 2.92973855 |
| 30 | adenine nucleotide transport (GO:0051503) | 2.92225773 |
| 31 | glutamate receptor signaling pathway (GO:0007215) | 2.92056323 |
| 32 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.92046396 |
| 33 | macroautophagy (GO:0016236) | 2.89963030 |
| 34 | one-carbon compound transport (GO:0019755) | 2.87693063 |
| 35 | postsynaptic membrane organization (GO:0001941) | 2.87667711 |
| 36 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.87645584 |
| 37 | potassium ion homeostasis (GO:0055075) | 2.86552544 |
| 38 | myofibril assembly (GO:0030239) | 2.85883507 |
| 39 | nonmotile primary cilium assembly (GO:0035058) | 2.85493000 |
| 40 | synaptic transmission, glutamatergic (GO:0035249) | 2.83054899 |
| 41 | linoleic acid metabolic process (GO:0043651) | 2.81833811 |
| 42 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.81411396 |
| 43 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.79529382 |
| 44 | presynaptic membrane organization (GO:0097090) | 2.78973763 |
| 45 | potassium ion import (GO:0010107) | 2.77641923 |
| 46 | regulation of bile acid biosynthetic process (GO:0070857) | 2.77325209 |
| 47 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.77128460 |
| 48 | positive regulation of synapse maturation (GO:0090129) | 2.76847532 |
| 49 | regulation of energy homeostasis (GO:2000505) | 2.76610407 |
| 50 | regulation of synaptic vesicle transport (GO:1902803) | 2.76582046 |
| 51 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.75631111 |
| 52 | detection of calcium ion (GO:0005513) | 2.75020828 |
| 53 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.71552130 |
| 54 | relaxation of smooth muscle (GO:0044557) | 2.71444182 |
| 55 | cardiac muscle contraction (GO:0060048) | 2.70781626 |
| 56 | striated muscle contraction (GO:0006941) | 2.70470543 |
| 57 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.70079514 |
| 58 | lactate metabolic process (GO:0006089) | 2.69747404 |
| 59 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.68669076 |
| 60 | negative regulation of astrocyte differentiation (GO:0048712) | 2.64811704 |
| 61 | regulation of cell communication by electrical coupling (GO:0010649) | 2.64709963 |
| 62 | creatine metabolic process (GO:0006600) | 2.63825210 |
| 63 | amino acid import (GO:0043090) | 2.61921741 |
| 64 | neurotransmitter secretion (GO:0007269) | 2.61342273 |
| 65 | fatty acid homeostasis (GO:0055089) | 2.61290337 |
| 66 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.60358781 |
| 67 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.60240810 |
| 68 | atrial cardiac muscle cell action potential (GO:0086014) | 2.58556031 |
| 69 | cAMP catabolic process (GO:0006198) | 2.58059962 |
| 70 | neuronal action potential propagation (GO:0019227) | 2.58051110 |
| 71 | negative regulation of gluconeogenesis (GO:0045721) | 2.57933269 |
| 72 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.57249707 |
| 73 | mechanoreceptor differentiation (GO:0042490) | 2.57108862 |
| 74 | C4-dicarboxylate transport (GO:0015740) | 2.56537839 |
| 75 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.55104365 |
| 76 | synaptic vesicle exocytosis (GO:0016079) | 2.54413239 |
| 77 | carnitine metabolic process (GO:0009437) | 2.53393736 |
| 78 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.53100150 |
| 79 | actin-mediated cell contraction (GO:0070252) | 2.52760023 |
| 80 | dentate gyrus development (GO:0021542) | 2.52445739 |
| 81 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.52409549 |
| 82 | purine ribonucleotide transport (GO:0015868) | 2.50745028 |
| 83 | purine nucleotide transport (GO:0015865) | 2.50365705 |
| 84 | regulation of synapse maturation (GO:0090128) | 2.49073724 |
| 85 | positive regulation of protein sumoylation (GO:0033235) | 2.48560560 |
| 86 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.47735530 |
| 87 | skeletal muscle adaptation (GO:0043501) | 2.46314548 |
| 88 | cell communication involved in cardiac conduction (GO:0086065) | 2.45831721 |
| 89 | neuronal ion channel clustering (GO:0045161) | 2.45648384 |
| 90 | chemosensory behavior (GO:0007635) | 2.45432707 |
| 91 | striatum development (GO:0021756) | 2.45309311 |
| 92 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.44527431 |
| 93 | cellular glucuronidation (GO:0052695) | 2.44250404 |
| 94 | photoreceptor cell maintenance (GO:0045494) | 2.44244089 |
| 95 | reverse cholesterol transport (GO:0043691) | 2.43823183 |
| 96 | response to epinephrine (GO:0071871) | 2.43805345 |
| 97 | cyclic nucleotide catabolic process (GO:0009214) | 2.42373435 |
| 98 | relaxation of muscle (GO:0090075) | 2.42300578 |
| 99 | urinary tract smooth muscle contraction (GO:0014848) | 2.41810928 |
| 100 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.41309637 |
| 101 | regulation of ARF protein signal transduction (GO:0032012) | 2.40923094 |
| 102 | regulation of relaxation of muscle (GO:1901077) | 2.40539095 |
| 103 | proline transport (GO:0015824) | 2.39197574 |
| 104 | eye photoreceptor cell development (GO:0042462) | 2.38914375 |
| 105 | sterol catabolic process (GO:0016127) | 2.38893224 |
| 106 | cholesterol catabolic process (GO:0006707) | 2.38893224 |
| 107 | skeletal muscle contraction (GO:0003009) | 2.38395274 |
| 108 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.37559549 |
| 109 | response to nitrosative stress (GO:0051409) | 2.36726741 |
| 110 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.36712954 |
| 111 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.36071599 |
| 112 | cardiac myofibril assembly (GO:0055003) | 2.34922148 |
| 113 | relaxation of cardiac muscle (GO:0055119) | 2.34638814 |
| 114 | cellular response to epinephrine stimulus (GO:0071872) | 2.34615423 |
| 115 | photoreceptor cell development (GO:0042461) | 2.32727594 |
| 116 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.32464861 |
| 117 | cell volume homeostasis (GO:0006884) | 2.32096599 |
| 118 | sleep (GO:0030431) | 2.31290913 |
| 119 | regulation of membrane repolarization (GO:0060306) | 2.31047897 |
| 120 | fructose metabolic process (GO:0006000) | 2.30287271 |
| 121 | neuron-neuron synaptic transmission (GO:0007270) | 2.29887989 |
| 122 | protein localization to synapse (GO:0035418) | 2.29836343 |
| 123 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.29298310 |
| 124 | regulation of beta-amyloid formation (GO:1902003) | 2.27878352 |
| 125 | intraciliary transport (GO:0042073) | 2.27602797 |
| 126 | membrane depolarization during action potential (GO:0086010) | 2.26570175 |
| 127 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.25023697 |
| 128 | protein-chromophore linkage (GO:0018298) | 2.24098886 |
| 129 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.24028473 |
| 130 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.24028473 |
| 131 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.23567555 |
| 132 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.23491894 |
| 133 | detection of light stimulus involved in visual perception (GO:0050908) | 2.23491894 |
| 134 | cell differentiation involved in metanephros development (GO:0072202) | 2.22381598 |
| 135 | locomotory exploration behavior (GO:0035641) | 2.22378304 |
| 136 | negative regulation of lipase activity (GO:0060192) | 2.21499410 |
| 137 | nucleotide transport (GO:0006862) | 2.21419791 |
| 138 | nucleotide transmembrane transport (GO:1901679) | 2.21068917 |
| 139 | startle response (GO:0001964) | 2.20847641 |
| 140 | amine catabolic process (GO:0009310) | 2.20208843 |
| 141 | cellular biogenic amine catabolic process (GO:0042402) | 2.20208843 |
| 142 | retinal cone cell development (GO:0046549) | 2.19804898 |
| 143 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.19731571 |
| 144 | regulation of actin filament-based movement (GO:1903115) | 2.19693429 |
| 145 | sulfate transmembrane transport (GO:1902358) | 2.19508316 |
| 146 | activation of protein kinase A activity (GO:0034199) | 2.19447333 |
| 147 | cardiac conduction (GO:0061337) | 2.18114584 |
| 148 | muscle contraction (GO:0006936) | 2.17599121 |
| 149 | long-term synaptic potentiation (GO:0060291) | 2.17587355 |
| 150 | central nervous system myelination (GO:0022010) | 2.17188739 |
| 151 | axon ensheathment in central nervous system (GO:0032291) | 2.17188739 |
| 152 | cardiac muscle hypertrophy (GO:0003300) | 2.17179152 |
| 153 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.16547867 |
| 154 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.16436839 |
| 155 | gamma-aminobutyric acid transport (GO:0015812) | 2.15948766 |
| 156 | regulation of male gonad development (GO:2000018) | 2.15929718 |
| 157 | neuromuscular process controlling balance (GO:0050885) | 2.15565930 |
| 158 | actin filament-based movement (GO:0030048) | 2.14371890 |
| 159 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.14238362 |
| 160 | striated muscle hypertrophy (GO:0014897) | 2.13864183 |
| 161 | cellular anion homeostasis (GO:0030002) | 2.13793777 |
| 162 | insulin secretion (GO:0030073) | 2.13290803 |
| 163 | cardiac muscle cell action potential (GO:0086001) | 2.13275749 |
| 164 | neurotransmitter transport (GO:0006836) | 2.13152465 |
| 165 | cellular sodium ion homeostasis (GO:0006883) | 2.12818927 |
| 166 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.12757821 |
| 167 | reflex (GO:0060004) | 2.11570599 |
| 168 | amino-acid betaine metabolic process (GO:0006577) | 2.11096606 |
| 169 | myelin maintenance (GO:0043217) | 2.10616969 |
| 170 | plasma membrane repair (GO:0001778) | 2.10578088 |
| 171 | glucuronate metabolic process (GO:0019585) | 2.10485113 |
| 172 | uronic acid metabolic process (GO:0006063) | 2.10485113 |
| 173 | protein-lipid complex remodeling (GO:0034368) | 2.10050020 |
| 174 | macromolecular complex remodeling (GO:0034367) | 2.10050020 |
| 175 | plasma lipoprotein particle remodeling (GO:0034369) | 2.10050020 |
| 176 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.09956039 |
| 177 | protein heterotetramerization (GO:0051290) | 2.09747912 |
| 178 | myotube differentiation (GO:0014902) | 2.09727549 |
| 179 | positive regulation of glucose import (GO:0046326) | 2.09700021 |
| 180 | import into cell (GO:0098657) | 2.09616396 |
| 181 | transmission of nerve impulse (GO:0019226) | 2.08981135 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.40970628 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.26929830 |
| 3 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.70272590 |
| 4 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.11643166 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.10224129 |
| 6 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.08864545 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.06458919 |
| 8 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.03188037 |
| 9 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.96678164 |
| 10 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.94912800 |
| 11 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.94518404 |
| 12 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.91520495 |
| 13 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.90790069 |
| 14 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.87617521 |
| 15 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.87274929 |
| 16 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.87166323 |
| 17 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.85734645 |
| 18 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.84683183 |
| 19 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.83555788 |
| 20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.79582649 |
| 21 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.78801015 |
| 22 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.77792573 |
| 23 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.77032246 |
| 24 | P300_19829295_ChIP-Seq_ESCs_Human | 1.73477830 |
| 25 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.73366872 |
| 26 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.70529697 |
| 27 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.70461066 |
| 28 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.68922535 |
| 29 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.68922535 |
| 30 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.67673294 |
| 31 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.67382347 |
| 32 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.66381361 |
| 33 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.62472561 |
| 34 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.61462670 |
| 35 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.58507270 |
| 36 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.57142666 |
| 37 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.55937131 |
| 38 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.55598472 |
| 39 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.53296264 |
| 40 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.51932122 |
| 41 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.51849034 |
| 42 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.50817531 |
| 43 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.50170984 |
| 44 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.50149933 |
| 45 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.49562179 |
| 46 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.49104414 |
| 47 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.48344324 |
| 48 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.47031227 |
| 49 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.46559929 |
| 50 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.46298304 |
| 51 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.45902160 |
| 52 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.45322793 |
| 53 | AR_25329375_ChIP-Seq_VCAP_Human | 1.45226234 |
| 54 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.44945015 |
| 55 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.44917981 |
| 56 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.44384974 |
| 57 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.42023243 |
| 58 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.41512493 |
| 59 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.41512493 |
| 60 | STAT3_23295773_ChIP-Seq_U87_Human | 1.41439516 |
| 61 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.39843555 |
| 62 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.39198729 |
| 63 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.38138030 |
| 64 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.37565988 |
| 65 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.37048869 |
| 66 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.37031729 |
| 67 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36579133 |
| 68 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.36488301 |
| 69 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.35199400 |
| 70 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.34625338 |
| 71 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.33461097 |
| 72 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.33414662 |
| 73 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.33311127 |
| 74 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.33117633 |
| 75 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.32850472 |
| 76 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31196597 |
| 77 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.30779995 |
| 78 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.29893349 |
| 79 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.27724705 |
| 80 | TCF4_23295773_ChIP-Seq_U87_Human | 1.25635983 |
| 81 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.24808674 |
| 82 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.24501488 |
| 83 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.24395153 |
| 84 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.24261394 |
| 85 | FUS_26573619_Chip-Seq_HEK293_Human | 1.24182513 |
| 86 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.22512767 |
| 87 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.22401177 |
| 88 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.22369009 |
| 89 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.21990712 |
| 90 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.21866599 |
| 91 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.21549945 |
| 92 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.20928918 |
| 93 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.19911504 |
| 94 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.18486242 |
| 95 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.18327278 |
| 96 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.17701647 |
| 97 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.16710614 |
| 98 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.16688431 |
| 99 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.16447771 |
| 100 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.16242633 |
| 101 | RXR_22108803_ChIP-Seq_LS180_Human | 1.16004349 |
| 102 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.15095950 |
| 103 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.14428483 |
| 104 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14388705 |
| 105 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.13617547 |
| 106 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.13228331 |
| 107 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.12518890 |
| 108 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.12128312 |
| 109 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.11905700 |
| 110 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.11877792 |
| 111 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.11527447 |
| 112 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.10825273 |
| 113 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.10780234 |
| 114 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.10367903 |
| 115 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10367903 |
| 116 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.10201488 |
| 117 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.09166458 |
| 118 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.09048151 |
| 119 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.07242923 |
| 120 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.07242923 |
| 121 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.06856758 |
| 122 | TP53_16413492_ChIP-PET_HCT116_Human | 1.05909518 |
| 123 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.05838931 |
| 124 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.05770304 |
| 125 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.05754492 |
| 126 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.05039988 |
| 127 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.04204624 |
| 128 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04190890 |
| 129 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.02990881 |
| 130 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02833115 |
| 131 | AR_19668381_ChIP-Seq_PC3_Human | 1.01864139 |
| 132 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.00234085 |
| 133 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99218006 |
| 134 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98454488 |
| 135 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.97741861 |
| 136 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97730979 |
| 137 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96249540 |
| 138 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.96154254 |
| 139 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.95864540 |
| 140 | CJUN_26792858_Chip-Seq_BT549_Human | 0.94368801 |
| 141 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.92974924 |
| 142 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92200230 |
| 143 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.91427501 |
| 144 | * CLOCK_20551151_ChIP-Seq_293T_Human | 0.90537281 |
| 145 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.89794001 |
| 146 | KDM2B_26808549_Chip-Seq_K562_Human | 0.87007619 |
| 147 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86302855 |
| 148 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.86136655 |
| 149 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84225125 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000566_synostosis | 4.21444104 |
| 2 | MP0003136_yellow_coat_color | 4.05233740 |
| 3 | MP0005670_abnormal_white_adipose | 3.71297851 |
| 4 | MP0006292_abnormal_olfactory_placode | 3.56991995 |
| 5 | MP0005646_abnormal_pituitary_gland | 3.53833932 |
| 6 | MP0005171_absent_coat_pigmentation | 3.01125293 |
| 7 | MP0004036_abnormal_muscle_relaxation | 2.96503226 |
| 8 | MP0001188_hyperpigmentation | 2.83691056 |
| 9 | MP0000751_myopathy | 2.74465943 |
| 10 | MP0003879_abnormal_hair_cell | 2.69265892 |
| 11 | MP0004145_abnormal_muscle_electrophysio | 2.64254356 |
| 12 | MP0005551_abnormal_eye_electrophysiolog | 2.52225407 |
| 13 | MP0002876_abnormal_thyroid_physiology | 2.50776241 |
| 14 | MP0004084_abnormal_cardiac_muscle | 2.46461654 |
| 15 | MP0010234_abnormal_vibrissa_follicle | 2.30276627 |
| 16 | MP0000749_muscle_degeneration | 2.27747263 |
| 17 | MP0005409_darkened_coat_color | 2.10350348 |
| 18 | * MP0001502_abnormal_circadian_rhythm | 2.09756494 |
| 19 | MP0008875_abnormal_xenobiotic_pharmacok | 2.09427347 |
| 20 | MP0002638_abnormal_pupillary_reflex | 2.07942982 |
| 21 | MP0009697_abnormal_copulation | 2.02410913 |
| 22 | MP0000747_muscle_weakness | 2.02368619 |
| 23 | MP0001984_abnormal_olfaction | 2.01909820 |
| 24 | MP0002971_abnormal_brown_adipose | 1.84826171 |
| 25 | MP0003880_abnormal_central_pattern | 1.84821165 |
| 26 | MP0001486_abnormal_startle_reflex | 1.81544558 |
| 27 | MP0003690_abnormal_glial_cell | 1.81407725 |
| 28 | MP0009745_abnormal_behavioral_response | 1.80829229 |
| 29 | MP0002254_reproductive_system_inflammat | 1.75161303 |
| 30 | MP0005275_abnormal_skin_tensile | 1.68435049 |
| 31 | MP0002909_abnormal_adrenal_gland | 1.67951057 |
| 32 | MP0005365_abnormal_bile_salt | 1.66546577 |
| 33 | MP0004087_abnormal_muscle_fiber | 1.65045279 |
| 34 | MP0004859_abnormal_synaptic_plasticity | 1.63055119 |
| 35 | MP0003045_fibrosis | 1.62704573 |
| 36 | MP0000920_abnormal_myelination | 1.62572581 |
| 37 | MP0002139_abnormal_hepatobiliary_system | 1.59447092 |
| 38 | MP0005253_abnormal_eye_physiology | 1.55517980 |
| 39 | MP0002269_muscular_atrophy | 1.55472937 |
| 40 | MP0005666_abnormal_adipose_tissue | 1.49644135 |
| 41 | MP0000013_abnormal_adipose_tissue | 1.47259155 |
| 42 | MP0000759_abnormal_skeletal_muscle | 1.46281068 |
| 43 | MP0003646_muscle_fatigue | 1.46260513 |
| 44 | MP0006138_congestive_heart_failure | 1.43929785 |
| 45 | MP0010329_abnormal_lipoprotein_level | 1.41853149 |
| 46 | MP0005620_abnormal_muscle_contractility | 1.41814015 |
| 47 | MP0003635_abnormal_synaptic_transmissio | 1.41648375 |
| 48 | MP0005647_abnormal_sex_gland | 1.40387851 |
| 49 | MP0002108_abnormal_muscle_morphology | 1.38841492 |
| 50 | MP0000678_abnormal_parathyroid_gland | 1.38115441 |
| 51 | MP0009780_abnormal_chondrocyte_physiolo | 1.38088401 |
| 52 | MP0004215_abnormal_myocardial_fiber | 1.37594399 |
| 53 | MP0003183_abnormal_peptide_metabolism | 1.36959155 |
| 54 | MP0002572_abnormal_emotion/affect_behav | 1.36486049 |
| 55 | MP0005375_adipose_tissue_phenotype | 1.32322872 |
| 56 | MP0004885_abnormal_endolymph | 1.31383001 |
| 57 | MP0002332_abnormal_exercise_endurance | 1.31304079 |
| 58 | MP0004233_abnormal_muscle_weight | 1.29758510 |
| 59 | MP0002557_abnormal_social/conspecific_i | 1.29384251 |
| 60 | MP0001986_abnormal_taste_sensitivity | 1.28772663 |
| 61 | MP0002106_abnormal_muscle_physiology | 1.25535746 |
| 62 | MP0005369_muscle_phenotype | 1.25090944 |
| 63 | MP0002090_abnormal_vision | 1.22812316 |
| 64 | MP0000003_abnormal_adipose_tissue | 1.22743005 |
| 65 | MP0002063_abnormal_learning/memory/cond | 1.22494963 |
| 66 | MP0001177_atelectasis | 1.22386486 |
| 67 | MP0010386_abnormal_urinary_bladder | 1.22140295 |
| 68 | MP0006072_abnormal_retinal_apoptosis | 1.20905057 |
| 69 | MP0009046_muscle_twitch | 1.20808180 |
| 70 | MP0000015_abnormal_ear_pigmentation | 1.20664307 |
| 71 | MP0002736_abnormal_nociception_after | 1.19287088 |
| 72 | MP0002822_catalepsy | 1.18062433 |
| 73 | MP0003878_abnormal_ear_physiology | 1.17973556 |
| 74 | MP0005377_hearing/vestibular/ear_phenot | 1.17973556 |
| 75 | MP0005595_abnormal_vascular_smooth | 1.17649112 |
| 76 | MP0002064_seizures | 1.17395821 |
| 77 | MP0002972_abnormal_cardiac_muscle | 1.15639999 |
| 78 | MP0002067_abnormal_sensory_capabilities | 1.13885673 |
| 79 | MP0004510_myositis | 1.13844050 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 1.13776537 |
| 81 | MP0004782_abnormal_surfactant_physiolog | 1.13731951 |
| 82 | MP0001661_extended_life_span | 1.13297291 |
| 83 | MP0005330_cardiomyopathy | 1.13226986 |
| 84 | MP0005499_abnormal_olfactory_system | 1.13103397 |
| 85 | MP0005394_taste/olfaction_phenotype | 1.13103397 |
| 86 | MP0005386_behavior/neurological_phenoty | 1.12665417 |
| 87 | MP0004924_abnormal_behavior | 1.12665417 |
| 88 | MP0008569_lethality_at_weaning | 1.10679840 |
| 89 | MP0003075_altered_response_to | 1.10034621 |
| 90 | MP0001324_abnormal_eye_pigmentation | 1.09162267 |
| 91 | MP0003011_delayed_dark_adaptation | 1.08944713 |
| 92 | MP0004043_abnormal_pH_regulation | 1.08671498 |
| 93 | MP0005645_abnormal_hypothalamus_physiol | 1.08578114 |
| 94 | MP0000372_irregular_coat_pigmentation | 1.07678124 |
| 95 | MP0004142_abnormal_muscle_tone | 1.06722869 |
| 96 | MP0002127_abnormal_cardiovascular_syste | 1.06640473 |
| 97 | MP0001968_abnormal_touch/_nociception | 1.06485547 |
| 98 | MP0005085_abnormal_gallbladder_physiolo | 1.06311063 |
| 99 | * MP0002272_abnormal_nervous_system | 1.04087120 |
| 100 | MP0001905_abnormal_dopamine_level | 1.03661519 |
| 101 | MP0001963_abnormal_hearing_physiology | 1.03401308 |
| 102 | MP0005058_abnormal_lysosome_morphology | 1.03372321 |
| 103 | MP0009384_cardiac_valve_regurgitation | 1.03089451 |
| 104 | MP0004130_abnormal_muscle_cell | 1.02127895 |
| 105 | MP0008789_abnormal_olfactory_epithelium | 1.01905214 |
| 106 | MP0001440_abnormal_grooming_behavior | 1.01013991 |
| 107 | MP0008995_early_reproductive_senescence | 1.00208764 |
| 108 | MP0005423_abnormal_somatic_nervous | 0.99938629 |
| 109 | MP0003631_nervous_system_phenotype | 0.99432577 |
| 110 | MP0003868_abnormal_feces_composition | 0.97916361 |
| 111 | * MP0001501_abnormal_sleep_pattern | 0.97423269 |
| 112 | MP0001485_abnormal_pinna_reflex | 0.96419795 |
| 113 | MP0003634_abnormal_glial_cell | 0.95286152 |
| 114 | MP0002796_impaired_skin_barrier | 0.94615377 |
| 115 | MP0002078_abnormal_glucose_homeostasis | 0.94239147 |
| 116 | MP0001299_abnormal_eye_distance/ | 0.94160573 |
| 117 | MP0004484_altered_response_of | 0.94009820 |
| 118 | MP0005503_abnormal_tendon_morphology | 0.90808904 |
| 119 | MP0002734_abnormal_mechanical_nocicepti | 0.90314612 |
| 120 | MP0008775_abnormal_heart_ventricle | 0.90273333 |
| 121 | MP0000049_abnormal_middle_ear | 0.89221839 |
| 122 | MP0004085_abnormal_heartbeat | 0.89098087 |
| 123 | MP0009840_abnormal_foam_cell | 0.87990260 |
| 124 | MP0003633_abnormal_nervous_system | 0.87219037 |
| 125 | MP0002132_abnormal_respiratory_system | 0.87098197 |
| 126 | MP0002735_abnormal_chemical_nociception | 0.86661704 |
| 127 | MP0000026_abnormal_inner_ear | 0.86151599 |
| 128 | MP0001764_abnormal_homeostasis | 0.85792617 |
| 129 | MP0002896_abnormal_bone_mineralization | 0.84869852 |
| 130 | MP0000631_abnormal_neuroendocrine_gland | 0.83828756 |
| 131 | MP0003632_abnormal_nervous_system | 0.83676167 |
| 132 | MP0003329_amyloid_beta_deposits | 0.81831579 |
| 133 | MP0002249_abnormal_larynx_morphology | 0.81228544 |
| 134 | MP0003950_abnormal_plasma_membrane | 0.80212299 |
| 135 | MP0004270_analgesia | 0.79249384 |
| 136 | MP0002066_abnormal_motor_capabilities/c | 0.78830872 |
| 137 | MP0005360_urolithiasis | 0.78694884 |
| 138 | MP0003787_abnormal_imprinting | 0.78668016 |
| 139 | MP0002118_abnormal_lipid_homeostasis | 0.77811141 |
| 140 | MP0001756_abnormal_urination | 0.77757674 |
| 141 | MP0002229_neurodegeneration | 0.77319139 |
| 142 | MP0009764_decreased_sensitivity_to | 0.76786323 |
| 143 | MP0002877_abnormal_melanocyte_morpholog | 0.76429750 |
| 144 | MP0009115_abnormal_fat_cell | 0.75504389 |
| 145 | MP0005332_abnormal_amino_acid | 0.75442449 |
| 146 | MP0004147_increased_porphyrin_level | 0.75221979 |
| 147 | MP0003137_abnormal_impulse_conducting | 0.75192795 |
| 148 | MP0003941_abnormal_skin_development | 0.74986806 |
| 149 | MP0010030_abnormal_orbit_morphology | 0.73659248 |
| 150 | MP0004019_abnormal_vitamin_homeostasis | 0.72844885 |
| 151 | MP0005334_abnormal_fat_pad | 0.72454146 |
| 152 | MP0002837_dystrophic_cardiac_calcinosis | 0.72412235 |
| 153 | MP0003195_calcinosis | 0.71748531 |
| 154 | MP0005535_abnormal_body_temperature | 0.69884644 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 4.50012749 |
| 2 | Nemaline bodies (HP:0003798) | 4.38738827 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.31529803 |
| 4 | Aplasia involving bones of the extremities (HP:0009825) | 4.25699257 |
| 5 | Aplasia involving bones of the upper limbs (HP:0009823) | 4.25699257 |
| 6 | Aplasia of the phalanges of the hand (HP:0009802) | 4.25699257 |
| 7 | Exercise-induced myalgia (HP:0003738) | 4.09498837 |
| 8 | Hyporeflexia of lower limbs (HP:0002600) | 4.05827047 |
| 9 | Bundle branch block (HP:0011710) | 3.70172569 |
| 10 | True hermaphroditism (HP:0010459) | 3.68049049 |
| 11 | Type 1 muscle fiber predominance (HP:0003803) | 3.66726430 |
| 12 | Congenital stationary night blindness (HP:0007642) | 3.54348381 |
| 13 | Chronic hepatic failure (HP:0100626) | 3.52322543 |
| 14 | Focal motor seizures (HP:0011153) | 3.51832125 |
| 15 | Hypoplasia of the fovea (HP:0007750) | 3.30012138 |
| 16 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.30012138 |
| 17 | Muscle fiber splitting (HP:0003555) | 3.26304915 |
| 18 | Exercise-induced muscle cramps (HP:0003710) | 3.23034556 |
| 19 | Febrile seizures (HP:0002373) | 3.20506075 |
| 20 | Pancreatic fibrosis (HP:0100732) | 3.12897856 |
| 21 | Obstructive sleep apnea (HP:0002870) | 3.10239865 |
| 22 | Epileptic encephalopathy (HP:0200134) | 3.08125647 |
| 23 | Renal cortical cysts (HP:0000803) | 3.07719329 |
| 24 | Papilledema (HP:0001085) | 3.07346251 |
| 25 | Action tremor (HP:0002345) | 3.04888959 |
| 26 | EMG: myopathic abnormalities (HP:0003458) | 3.04036788 |
| 27 | Abnormality of secondary sexual hair (HP:0009888) | 3.02833044 |
| 28 | Abnormality of the axillary hair (HP:0100134) | 3.02833044 |
| 29 | Sudden death (HP:0001699) | 2.95712881 |
| 30 | Hypoglycemic seizures (HP:0002173) | 2.94893907 |
| 31 | Dysmetric saccades (HP:0000641) | 2.93883212 |
| 32 | Median cleft lip (HP:0000161) | 2.80902352 |
| 33 | Hypoglycemic coma (HP:0001325) | 2.78913388 |
| 34 | Abnormality of the fovea (HP:0000493) | 2.76169679 |
| 35 | Frequent falls (HP:0002359) | 2.75965582 |
| 36 | Tubulointerstitial nephritis (HP:0001970) | 2.71581418 |
| 37 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.69003350 |
| 38 | Subaortic stenosis (HP:0001682) | 2.69003350 |
| 39 | Ventricular fibrillation (HP:0001663) | 2.61872528 |
| 40 | Hyperglycinuria (HP:0003108) | 2.61348748 |
| 41 | Heart block (HP:0012722) | 2.60019393 |
| 42 | Onycholysis (HP:0001806) | 2.58036463 |
| 43 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.55610636 |
| 44 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.55528785 |
| 45 | Blue irides (HP:0000635) | 2.53499044 |
| 46 | Abnormal atrioventricular conduction (HP:0005150) | 2.53317741 |
| 47 | Neurofibrillary tangles (HP:0002185) | 2.53142820 |
| 48 | Lip pit (HP:0100267) | 2.50582798 |
| 49 | Stomach cancer (HP:0012126) | 2.50153881 |
| 50 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.48295902 |
| 51 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.47160915 |
| 52 | Occipital encephalocele (HP:0002085) | 2.46224115 |
| 53 | Myoglobinuria (HP:0002913) | 2.45753235 |
| 54 | Dry hair (HP:0011359) | 2.44972731 |
| 55 | Medial flaring of the eyebrow (HP:0010747) | 2.43954379 |
| 56 | Difficulty running (HP:0009046) | 2.42416745 |
| 57 | Pancreatic cysts (HP:0001737) | 2.41998769 |
| 58 | Renal tubular acidosis (HP:0001947) | 2.40475762 |
| 59 | Nephrogenic diabetes insipidus (HP:0009806) | 2.39405750 |
| 60 | Congenital primary aphakia (HP:0007707) | 2.38097473 |
| 61 | Asymmetric septal hypertrophy (HP:0001670) | 2.37970165 |
| 62 | Methylmalonic acidemia (HP:0002912) | 2.37839962 |
| 63 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.37793107 |
| 64 | Increased circulating renin level (HP:0000848) | 2.37482305 |
| 65 | Increased connective tissue (HP:0009025) | 2.36736999 |
| 66 | Osteomalacia (HP:0002749) | 2.35932912 |
| 67 | Supranuclear gaze palsy (HP:0000605) | 2.35145831 |
| 68 | Decreased central vision (HP:0007663) | 2.33575197 |
| 69 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.32252892 |
| 70 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.31054759 |
| 71 | Increased variability in muscle fiber diameter (HP:0003557) | 2.30428606 |
| 72 | Bile duct proliferation (HP:0001408) | 2.29990455 |
| 73 | Abnormal biliary tract physiology (HP:0012439) | 2.29990455 |
| 74 | Distal lower limb muscle weakness (HP:0009053) | 2.28712617 |
| 75 | Severe visual impairment (HP:0001141) | 2.26796993 |
| 76 | Gait imbalance (HP:0002141) | 2.26567539 |
| 77 | Abnormality of molar (HP:0011077) | 2.25804370 |
| 78 | Abnormality of molar morphology (HP:0011070) | 2.25804370 |
| 79 | Hyperventilation (HP:0002883) | 2.25647184 |
| 80 | Absence seizures (HP:0002121) | 2.24618701 |
| 81 | Focal seizures (HP:0007359) | 2.20874655 |
| 82 | Abnormality of permanent molar morphology (HP:0011071) | 2.20712332 |
| 83 | Abnormality of the dental root (HP:0006486) | 2.20712332 |
| 84 | Taurodontia (HP:0000679) | 2.20712332 |
| 85 | Neck muscle weakness (HP:0000467) | 2.20310394 |
| 86 | Abnormality of midbrain morphology (HP:0002418) | 2.19902737 |
| 87 | Molar tooth sign on MRI (HP:0002419) | 2.19902737 |
| 88 | Complement deficiency (HP:0004431) | 2.19162291 |
| 89 | Abnormality of the dental pulp (HP:0006479) | 2.18668073 |
| 90 | Ankle clonus (HP:0011448) | 2.18070937 |
| 91 | Congenital hepatic fibrosis (HP:0002612) | 2.17414513 |
| 92 | Abnormality of the calf musculature (HP:0001430) | 2.16903924 |
| 93 | Postaxial foot polydactyly (HP:0001830) | 2.15457129 |
| 94 | Hyperglycemia (HP:0003074) | 2.15380911 |
| 95 | Abnormality of incisor morphology (HP:0011063) | 2.14760579 |
| 96 | Alveolar cell carcinoma (HP:0006519) | 2.14704513 |
| 97 | EMG: neuropathic changes (HP:0003445) | 2.14096542 |
| 98 | Progressive cerebellar ataxia (HP:0002073) | 2.11412892 |
| 99 | Cystic liver disease (HP:0006706) | 2.11201103 |
| 100 | Calf muscle hypertrophy (HP:0008981) | 2.11082018 |
| 101 | Fair hair (HP:0002286) | 2.10807909 |
| 102 | Atonic seizures (HP:0010819) | 2.10705989 |
| 103 | Abnormality of binocular vision (HP:0011514) | 2.10172106 |
| 104 | Diplopia (HP:0000651) | 2.10172106 |
| 105 | Poor coordination (HP:0002370) | 2.10153762 |
| 106 | Optic nerve hypoplasia (HP:0000609) | 2.09566425 |
| 107 | Abnormal hair whorl (HP:0010721) | 2.08316960 |
| 108 | Round ear (HP:0100830) | 2.07833182 |
| 109 | Abnormality of the renal cortex (HP:0011035) | 2.07177143 |
| 110 | Cerebral aneurysm (HP:0004944) | 2.06956499 |
| 111 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.06003439 |
| 112 | Truncal ataxia (HP:0002078) | 2.05488005 |
| 113 | Myopathic facies (HP:0002058) | 2.05252844 |
| 114 | Atrioventricular block (HP:0001678) | 2.01925418 |
| 115 | Central scotoma (HP:0000603) | 2.01897877 |
| 116 | Prolonged QT interval (HP:0001657) | 2.01470490 |
| 117 | Abnormality of macular pigmentation (HP:0008002) | 1.99949711 |
| 118 | Nephronophthisis (HP:0000090) | 1.99583976 |
| 119 | Ventricular arrhythmia (HP:0004308) | 1.99190649 |
| 120 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.98641335 |
| 121 | Preaxial hand polydactyly (HP:0001177) | 1.97942953 |
| 122 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.97065779 |
| 123 | White forelock (HP:0002211) | 1.96774435 |
| 124 | Decreased circulating renin level (HP:0003351) | 1.96632654 |
| 125 | Hypothermia (HP:0002045) | 1.96107520 |
| 126 | Hypoplastic left heart (HP:0004383) | 1.95527604 |
| 127 | Pigmentary retinal degeneration (HP:0001146) | 1.94329886 |
| 128 | Syncope (HP:0001279) | 1.94315000 |
| 129 | Cerebral inclusion bodies (HP:0100314) | 1.94116314 |
| 130 | Absent hair (HP:0002298) | 1.94090718 |
| 131 | Renal dysplasia (HP:0000110) | 1.92726626 |
| 132 | Postural instability (HP:0002172) | 1.92451439 |
| 133 | Mixed hearing impairment (HP:0000410) | 1.92420415 |
| 134 | Anxiety (HP:0000739) | 1.92342894 |
| 135 | Macroorchidism (HP:0000053) | 1.91865325 |
| 136 | Thyroid-stimulating hormone excess (HP:0002925) | 1.91619418 |
| 137 | Generalized tonic-clonic seizures (HP:0002069) | 1.90350214 |
| 138 | Abnormality of the renal medulla (HP:0100957) | 1.88242693 |
| 139 | Atrial fibrillation (HP:0005110) | 1.87501738 |
| 140 | Dysdiadochokinesis (HP:0002075) | 1.87398955 |
| 141 | Visual hallucinations (HP:0002367) | 1.87158099 |
| 142 | Patchy hypopigmentation of hair (HP:0011365) | 1.86165278 |
| 143 | Genetic anticipation (HP:0003743) | 1.85062389 |
| 144 | Foot dorsiflexor weakness (HP:0009027) | 1.82664208 |
| 145 | Generalized aminoaciduria (HP:0002909) | 1.82516312 |
| 146 | Homocystinuria (HP:0002156) | 1.81897959 |
| 147 | Abnormality of homocysteine metabolism (HP:0010919) | 1.81897959 |
| 148 | Male pseudohermaphroditism (HP:0000037) | 1.81665766 |
| 149 | Abnormality of methionine metabolism (HP:0010901) | 1.81452584 |
| 150 | Hyperlipoproteinemia (HP:0010980) | 1.80862213 |
| 151 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.80725434 |
| 152 | Intention tremor (HP:0002080) | 1.80160418 |
| 153 | Increased corneal curvature (HP:0100692) | 1.79795135 |
| 154 | Keratoconus (HP:0000563) | 1.79795135 |
| 155 | Split foot (HP:0001839) | 1.78942446 |
| 156 | Abnormal ciliary motility (HP:0012262) | 1.78790577 |
| 157 | Rimmed vacuoles (HP:0003805) | 1.77653710 |
| 158 | Protruding tongue (HP:0010808) | 1.76894490 |
| 159 | Generalized hypopigmentation of hair (HP:0011358) | 1.76270684 |
| 160 | Myokymia (HP:0002411) | 1.76091612 |
| 161 | Lower limb amyotrophy (HP:0007210) | 1.75672817 |
| 162 | Hypoalphalipoproteinemia (HP:0003233) | 1.75524281 |
| 163 | Fetal akinesia sequence (HP:0001989) | 1.75473697 |
| 164 | Renal tubular dysfunction (HP:0000124) | 1.75389584 |
| 165 | Rhabdomyolysis (HP:0003201) | 1.74969946 |
| 166 | Dialeptic seizures (HP:0011146) | 1.74429928 |
| 167 | Genital tract atresia (HP:0001827) | 1.74202502 |
| 168 | Congenital sensorineural hearing impairment (HP:0008527) | 1.73904680 |
| 169 | Right ventricular cardiomyopathy (HP:0011663) | 1.73283793 |
| 170 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.73209416 |
| 171 | Gaze-evoked nystagmus (HP:0000640) | 1.72988752 |
| 172 | Nonprogressive disorder (HP:0003680) | 1.72749080 |
| 173 | Abnormality of the foot musculature (HP:0001436) | 1.72134440 |
| 174 | Nasolacrimal duct obstruction (HP:0000579) | 1.71769649 |
| 175 | Symptomatic seizures (HP:0011145) | 1.71505692 |
| 176 | Vaginal atresia (HP:0000148) | 1.71418013 |
| 177 | Hyperphosphatemia (HP:0002905) | 1.70972382 |
| 178 | Hyperkalemia (HP:0002153) | 1.70841205 |
| 179 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.70829688 |
| 180 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.70300505 |
| 181 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.70300505 |
| 182 | Abnormality of glycolipid metabolism (HP:0010969) | 1.70300505 |
| 183 | Menstrual irregularities (HP:0000858) | 1.69767598 |
| 184 | Depression (HP:0000716) | 1.69294902 |
| 185 | Abnormal eating behavior (HP:0100738) | 1.66765729 |
| 186 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.66537480 |
| 187 | Distal lower limb amyotrophy (HP:0008944) | 1.65582211 |
| 188 | Scanning speech (HP:0002168) | 1.65394815 |
| 189 | Polar cataract (HP:0010696) | 1.64591952 |
| 190 | Rigidity (HP:0002063) | 1.64256407 |
| 191 | Stridor (HP:0010307) | 1.63737237 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 5.37701378 |
| 2 | CASK | 3.71554625 |
| 3 | MUSK | 3.46398851 |
| 4 | INSRR | 3.28929629 |
| 5 | PRPF4B | 3.24578084 |
| 6 | RIPK1 | 3.06019114 |
| 7 | MKNK2 | 2.88732380 |
| 8 | SGK2 | 2.58203325 |
| 9 | EPHA4 | 2.56019443 |
| 10 | PINK1 | 2.34744858 |
| 11 | MAP2K7 | 2.29005465 |
| 12 | NTRK3 | 2.19429544 |
| 13 | AKT3 | 2.15396791 |
| 14 | MAP3K9 | 2.13237377 |
| 15 | TTN | 2.04511366 |
| 16 | ZAK | 1.91049453 |
| 17 | SGK3 | 1.75749282 |
| 18 | DMPK | 1.71577972 |
| 19 | TAOK2 | 1.69032187 |
| 20 | MAP3K2 | 1.68849979 |
| 21 | SGK494 | 1.67374825 |
| 22 | SGK223 | 1.67374825 |
| 23 | CDK3 | 1.63385369 |
| 24 | MAPK13 | 1.60756785 |
| 25 | LATS2 | 1.55434119 |
| 26 | IRAK3 | 1.54174030 |
| 27 | NEK6 | 1.46333451 |
| 28 | BMPR2 | 1.46080187 |
| 29 | SIK3 | 1.42635035 |
| 30 | SIK1 | 1.41859760 |
| 31 | PHKG1 | 1.40429790 |
| 32 | PHKG2 | 1.40429790 |
| 33 | WNK1 | 1.40095319 |
| 34 | PAK6 | 1.38252828 |
| 35 | STK38L | 1.28434745 |
| 36 | TNK2 | 1.28192200 |
| 37 | MAPKAPK3 | 1.24848423 |
| 38 | LATS1 | 1.23543052 |
| 39 | MKNK1 | 1.20944673 |
| 40 | LMTK2 | 1.20750019 |
| 41 | MET | 1.18568895 |
| 42 | FGFR2 | 1.18333966 |
| 43 | UHMK1 | 1.17681957 |
| 44 | BRD4 | 1.17555876 |
| 45 | MARK1 | 1.17374573 |
| 46 | CAMKK1 | 1.15963617 |
| 47 | EEF2K | 1.14927129 |
| 48 | GRK1 | 1.12763558 |
| 49 | PRKD3 | 1.09011923 |
| 50 | KSR2 | 1.06038324 |
| 51 | PRKCH | 1.05833656 |
| 52 | BCKDK | 1.05251586 |
| 53 | MAP3K13 | 1.04555144 |
| 54 | MAP3K14 | 1.04152139 |
| 55 | ICK | 0.97123427 |
| 56 | MAPK7 | 0.95533427 |
| 57 | FER | 0.94773885 |
| 58 | PRKAA2 | 0.93258300 |
| 59 | NTRK1 | 0.92422594 |
| 60 | ERBB3 | 0.91061379 |
| 61 | CAMK1 | 0.90948160 |
| 62 | DAPK2 | 0.90282249 |
| 63 | TESK1 | 0.89577819 |
| 64 | NUAK1 | 0.89538173 |
| 65 | MAP3K4 | 0.88603225 |
| 66 | PIK3CA | 0.88600534 |
| 67 | MAP3K6 | 0.85005514 |
| 68 | CAMK2B | 0.83852280 |
| 69 | NTRK2 | 0.82960591 |
| 70 | MAPK15 | 0.82844294 |
| 71 | PDGFRA | 0.82021867 |
| 72 | MAP3K3 | 0.80790575 |
| 73 | MAP3K7 | 0.80617034 |
| 74 | PRKCE | 0.80249383 |
| 75 | TIE1 | 0.78832848 |
| 76 | MAPK10 | 0.77774140 |
| 77 | MAPK12 | 0.77182318 |
| 78 | BMPR1B | 0.76068100 |
| 79 | SGK1 | 0.76067377 |
| 80 | PRKCG | 0.75204377 |
| 81 | TRIB3 | 0.75002490 |
| 82 | ACVR1B | 0.74729829 |
| 83 | BRAF | 0.74625588 |
| 84 | EIF2AK2 | 0.73105571 |
| 85 | PDPK1 | 0.70437320 |
| 86 | ROCK1 | 0.69739352 |
| 87 | CDK8 | 0.69598293 |
| 88 | STK38 | 0.68657244 |
| 89 | TEC | 0.67325585 |
| 90 | CDK5 | 0.67073270 |
| 91 | CDC42BPA | 0.65554674 |
| 92 | TAOK3 | 0.65469823 |
| 93 | PDK1 | 0.65332423 |
| 94 | TGFBR2 | 0.65080847 |
| 95 | MAP3K1 | 0.64852848 |
| 96 | NLK | 0.64484398 |
| 97 | PDGFRB | 0.64369682 |
| 98 | NEK9 | 0.62947893 |
| 99 | PKN1 | 0.62775176 |
| 100 | DYRK1A | 0.62584594 |
| 101 | ADRBK2 | 0.62421731 |
| 102 | CAMK2A | 0.61237072 |
| 103 | ARAF | 0.61109983 |
| 104 | PTK2 | 0.60677641 |
| 105 | RPS6KA3 | 0.58026563 |
| 106 | CAMK4 | 0.58015175 |
| 107 | PRKD2 | 0.57377236 |
| 108 | OBSCN | 0.56799522 |
| 109 | MTOR | 0.56064350 |
| 110 | RPS6KB1 | 0.56025762 |
| 111 | RET | 0.55910166 |
| 112 | GRK7 | 0.55411936 |
| 113 | MAP2K1 | 0.54907192 |
| 114 | CAMK1D | 0.53959791 |
| 115 | DDR2 | 0.53211769 |
| 116 | MINK1 | 0.52639498 |
| 117 | MYLK | 0.52536955 |
| 118 | MAP2K4 | 0.51753474 |
| 119 | MOS | 0.51123935 |
| 120 | PAK3 | 0.50868410 |
| 121 | PRKD1 | 0.50698819 |
| 122 | STK24 | 0.49677468 |
| 123 | MST1R | 0.49009204 |
| 124 | FES | 0.46278673 |
| 125 | CAMK2D | 0.45299013 |
| 126 | TRPM7 | 0.42926453 |
| 127 | MARK2 | 0.42731224 |
| 128 | STK3 | 0.42296953 |
| 129 | PRKAA1 | 0.40401782 |
| 130 | PRKACA | 0.40369072 |
| 131 | CAMK2G | 0.39758704 |
| 132 | PRKG1 | 0.39367762 |
| 133 | CAMKK2 | 0.37645040 |
| 134 | CAMK1G | 0.37615719 |
| 135 | TXK | 0.37610626 |
| 136 | PTK2B | 0.37095329 |
| 137 | PRKCA | 0.36684691 |
| 138 | CDK9 | 0.35795462 |
| 139 | MAP2K6 | 0.35384352 |
| 140 | PIK3CG | 0.35000991 |
| 141 | JAK1 | 0.30230975 |
| 142 | FRK | 0.29602158 |
| 143 | YES1 | 0.29525537 |
| 144 | PLK2 | 0.27815023 |
| 145 | CSNK1A1 | 0.27802050 |
| 146 | IKBKE | 0.27660821 |
| 147 | PRKACB | 0.26490230 |
| 148 | HIPK2 | 0.26229705 |
| 149 | MAP3K12 | 0.26064122 |
| 150 | FGFR3 | 0.26040091 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.68095693 |
| 2 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.42570758 |
| 3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.18973222 |
| 4 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.14826421 |
| 5 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.10299768 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.04582748 |
| 7 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.00821967 |
| 8 | Phototransduction_Homo sapiens_hsa04744 | 1.99554674 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.97198313 |
| 10 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.94234327 |
| 11 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.85119083 |
| 12 | Peroxisome_Homo sapiens_hsa04146 | 1.82926008 |
| 13 | * Circadian rhythm_Homo sapiens_hsa04710 | 1.82669754 |
| 14 | Morphine addiction_Homo sapiens_hsa05032 | 1.74449936 |
| 15 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.64817178 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 1.63788095 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.63741480 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.62963594 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.62906082 |
| 20 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.62507094 |
| 21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.61482533 |
| 22 | ABC transporters_Homo sapiens_hsa02010 | 1.61150352 |
| 23 | * Circadian entrainment_Homo sapiens_hsa04713 | 1.60318179 |
| 24 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.60148779 |
| 25 | Olfactory transduction_Homo sapiens_hsa04740 | 1.58982523 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.58105167 |
| 27 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.56518750 |
| 28 | GABAergic synapse_Homo sapiens_hsa04727 | 1.56104615 |
| 29 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.54323946 |
| 30 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.52692962 |
| 31 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.48048387 |
| 32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.47049320 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.41622343 |
| 34 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.41002166 |
| 35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.36387786 |
| 36 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.34190498 |
| 37 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.30392561 |
| 38 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.27634614 |
| 39 | Taste transduction_Homo sapiens_hsa04742 | 1.25941300 |
| 40 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.25447333 |
| 41 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.24400657 |
| 42 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.22721532 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.21374921 |
| 44 | Salivary secretion_Homo sapiens_hsa04970 | 1.18731468 |
| 45 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.09398754 |
| 46 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.08542208 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.08235859 |
| 48 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.03765664 |
| 49 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.01591454 |
| 50 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.01276849 |
| 51 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.01190590 |
| 52 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.99378032 |
| 53 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.99273163 |
| 54 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.99136793 |
| 55 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.98943953 |
| 56 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.97368121 |
| 57 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.96142703 |
| 58 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.95956770 |
| 59 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.95931733 |
| 60 | Bile secretion_Homo sapiens_hsa04976 | 0.93371170 |
| 61 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.93255861 |
| 62 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.91498254 |
| 63 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.90151048 |
| 64 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.89149296 |
| 65 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.88195531 |
| 66 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.86964952 |
| 67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.86585638 |
| 68 | Renin secretion_Homo sapiens_hsa04924 | 0.86550757 |
| 69 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.84649704 |
| 70 | Histidine metabolism_Homo sapiens_hsa00340 | 0.84003255 |
| 71 | Cocaine addiction_Homo sapiens_hsa05030 | 0.83339628 |
| 72 | Insulin resistance_Homo sapiens_hsa04931 | 0.82099603 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.80535983 |
| 74 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.80167039 |
| 75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.80129832 |
| 76 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.79669414 |
| 77 | Prion diseases_Homo sapiens_hsa05020 | 0.79574944 |
| 78 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.79560878 |
| 79 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.76280884 |
| 80 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.75648782 |
| 81 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.74890011 |
| 82 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.74536780 |
| 83 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.74090258 |
| 84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73646388 |
| 85 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.72299948 |
| 86 | Long-term potentiation_Homo sapiens_hsa04720 | 0.71502062 |
| 87 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.71260784 |
| 88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.70930974 |
| 89 | Glioma_Homo sapiens_hsa05214 | 0.70612408 |
| 90 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.68248365 |
| 91 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.67194164 |
| 92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.67075405 |
| 93 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.66208008 |
| 94 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.65404995 |
| 95 | Gap junction_Homo sapiens_hsa04540 | 0.63994198 |
| 96 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.63627644 |
| 97 | Mineral absorption_Homo sapiens_hsa04978 | 0.63313879 |
| 98 | Melanogenesis_Homo sapiens_hsa04916 | 0.62514621 |
| 99 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.61980899 |
| 100 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.61811180 |
| 101 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.61775291 |
| 102 | Lysine degradation_Homo sapiens_hsa00310 | 0.61488434 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60634562 |
| 104 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.60293708 |
| 105 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.60275867 |
| 106 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.59975580 |
| 107 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.59891142 |
| 108 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.59590128 |
| 109 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.59120186 |
| 110 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58856238 |
| 111 | Lysosome_Homo sapiens_hsa04142 | 0.56816209 |
| 112 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.55737910 |
| 113 | Focal adhesion_Homo sapiens_hsa04510 | 0.55308355 |
| 114 | Tight junction_Homo sapiens_hsa04530 | 0.54509026 |
| 115 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.54481762 |
| 116 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.53781071 |
| 117 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.52615282 |
| 118 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.51233381 |
| 119 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.51015887 |
| 120 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.50875716 |
| 121 | Long-term depression_Homo sapiens_hsa04730 | 0.49715986 |
| 122 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.48257445 |
| 123 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.47315240 |
| 124 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.46545187 |
| 125 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46383564 |
| 126 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.46285000 |
| 127 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.46232904 |
| 128 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45539806 |
| 129 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.44957328 |
| 130 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44747556 |
| 131 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.44033928 |
| 132 | Amoebiasis_Homo sapiens_hsa05146 | 0.43499163 |
| 133 | Adherens junction_Homo sapiens_hsa04520 | 0.42625088 |
| 134 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.42200344 |
| 135 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.42178176 |
| 136 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41840810 |
| 137 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.41169572 |
| 138 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40785624 |
| 139 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.40140470 |
| 140 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39476224 |

